SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

    Antonio González-Martín, M.D., Ph.D., Bhavana Pothuri, M.D., Ignace Vergote, M.D., Ph.D., René DePont Christensen, Ph.D., Whitney Graybill, M.D., Mansoor R. Mirza, M.D., Colleen McCormick, M.D., M.P.H., Domenica Lorusso, M.D., Ph.D., Paul Hoskins, M.D., Gilles Freyer, M.D., Klaus Baumann, M.D., Kris Jardon, M.D., et al., for the PRIMA/ENGOT-OV26/GOG-3012 Investigators*

    From Grupo Español de Investigación en Cáncer de Ovario (GEICO) and the Medical Oncology Department, Clínica Universidad de Navarra (A.G.-M.) and GEICO and Hospital Universitario La Paz-IdiPAZ (A.R.), Madrid, GEICO and Medical Oncology, Catalan Institute of Oncology, Girona Biomedical Research Institute, and the Department of Medical Sciences, Medical School University of Girona, Girona (P.B.-G.), and GEICO and Hospital Universitario Reina Sofía, Cordoba (M.J.R.-P.) - all in Spain; the Gynecologic Oncology Group (GOG) and the Department of Obstetrics/Gynecology, Perlmutter Cancer Center, NYU Langone Health (B.P.), and GOG and the Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College (R.E.O.), New York, and US Oncology Research (USOR) and the Division of Gynecologic Oncology, Wilmot Cancer Institute, Department of Obstetrics and Gynecology, University of Rochester, Rochester (R.G.M.) - all in New York; Belgium and Luxembourg Gynecologic Oncology Group (BGOG) and the Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven (I.V.), BGOG and the Department of Medical Oncology and Hematology, AZ Maria Middelares, Ghent (C.V.), and the Department of Molecular Imaging, Pathology, Radiotherapy, and Oncology, Center for Oncological Research, Antwerp University, Antwerp (C.V.) - all in Belgium; the Nordic Society of Gynecologic Oncology (NSGO) and the Research Unit of General Practice, Institute of Public Health, University of Southern Denmark, Odense (R.D.C.), NSGO and Rigshospitalet-Copenhagen University Hospital, Copenhagen (M.R.M.), and NSGO and the Department of Oncology, Aalborg University, Aalborg (B.L.) - all in Denmark; GOG and Gynecologic Oncology, Medical University of South Carolina, Charleston (W.G.); GOG and Legacy Medical Group Gynecologic Oncology, Portland, OR (C.M.); Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) and Fondazione IRCCS National Cancer Institute of Milan (D.L.), and MITO and the Department of Obstetrics and Gynecology, San Raffaele Scientific Institute (G.M.) - both in Milan; USOR and the Department of Medical Oncology, BC Cancer, Vancouver, BC (P.H.), and GOG and the Department of Obstetrics and Gynecology, McGill University, and the Department of Oncology, McGill University Health Centre, Division of Gynecologic Oncology, Montreal (K.J.) - all in Canada; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens and Service d'Oncologie Médicale, Centre Hospitalier Lyon-Sud, Lyon, France (G.F.); Arbeitsgemeinschaft Gynäkologische Onkologie and the Department of Gynecology and Obstetrics, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany (K.B.); the Division of Gynecologic Oncology, Ohio State University, Columbus (F.B.); GOG and the Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia (A.F.H.), and GOG and Hanjani Institute for Gynecologic Oncology, Asplundh Cancer Pavilion, Abington Jefferson Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Willow Grove (M.S.S.) - all in Pennsylvania; GOG and the Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee (W.H.B.); Israeli Society of Gynecologic Oncology and Department of Gynecology and Gynecologic Oncology, Hillel Yaffe Medical Center, Technion Israel Institute of Technology, Haifa, Israel (I.B.); GlaxoSmithKline/Tesaro, Waltham, MA (K.S., I.A.M., Y.L., D.G.); and Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix (B.J.M.).

    The New England Journal of Medicine 28 SEPTEMBER 2019

  • NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling

    Unamuno X (1,2), Gómez-Ambrosi J (1,2,3), Ramírez B (1,2,3), Rodríguez A (1,2,3), Becerril S (1,2,3), Valentí V (2,3,4), Moncada R (2,3,5), Silva C (2,6), Salvador J (2,6), Frühbeck G (7,8,9,10), Catalán V (11,12,13).

    (1) Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
    (3) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (4) Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
    (5) Department of Anesthesia, Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.
    (7) Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain.
    (8) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
    (9) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (10) Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.
    (11) Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain.
    (12) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
    (13) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.

    Cellular Molecular Immunology 24 SEPTEMBER 2019

  • Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine

    Diener HC (1), Goadsby PJ (2), Ashina M (3), Al-Karagholi MA (3), Sinclair A (4), Mitsikostas D (5), Magis D (6), Pozo-Rosich P (7,8), Sieira PI (9), Làinez MJ (10), Gaul C (11), Silver N (12), Hoffmann J (2), Marin J (2), Liebler E (13), Ferrari MD (14); PREMIUM Study Group.

    (1) Faculty of Medicine, University Duisburg-Essen, Essen, Germany.
    (2) NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, UK.
    (3) Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen, Copenhagen, Denmark.
    (4) Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
    (5) 1st Neurology Department, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
    (6) Neurology Department and Pain Clinic, CHR East Belgium, Liège, Belgium.
    (7) Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
    (8) Headache Research Group, Vall d'Hebron Research Institute, Universitat Autonoma de Barcelona, Barcelona, Spain.
    (9) Clinica Universidad de Navarra, Pamplona, Spain.
    (10) Catholic University of Valencia, University Clinic Hospital, Valencia, Spain.
    (11) Migraine and Headache Clinic, Königstein, Germany.
    (12) The Walton Centre, Liverpool, UK.
    (13) electroCore, Inc., Basking Ridge, New Jersey, USA.
    (14) Leiden University Medical Center, Leiden, The Netherlands.

    Cephalalgia 15 SEPTEMBER 2019

  • Novel Association of High C-Reactive Protein Levels and A69S at Risk Alleles in Wet Age-Related Macular Degeneration Women

    Fernandez-Robredo P (1,2), Recalde S (1,2), Hernandez M (1,2), Zarranz-Ventura J (3,4), Molins B (3), Casaroli-Marano RP (3), Adan A (3,4), Saenz-de-Viteri M (5,6), García-Layana A (1,2,5).

    (1) Experimental Ophthalmology Laboratory, Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.
    (2) Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (3) Hospital Clínic, Institut Clínic d'Oftalmologia (ICOF), Barcelona, Spain.
    (4) Fundació Clínic per a la Recerca Biomèdica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
    (5) Ophthalmology, Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Royal Eye Infirmary, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.

    Frontiers in Immunology 01 AUGUST 2019

  • New mapping tools to assess lesion in atrial fibrillation

    García-Bolao I (1), Ramos P (1), Ballesteros G (1), Vives E (1).

    (1) Department of Cardiology and Cardiac Surgery, Clínica Universidad de Navarra, Avda. Pío XII 36, Pamplona, Spain.

    Europace 01 AUGUST 2019

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra